Open access
Open access
Powered by Google Translator Translator

RCT | Cemiplimab plus chemotherapy vs. chemotherapy alone in non-small cell lung cancer.

29 Aug, 2022 | 12:08h | UTC

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial – Nature Medicine

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.